Neonatal and paediatric laboratory medicine, including prenatal testing

Articles in the same Issue

1. Frontmatter
2. Committees
3. Contents
4. Speakers Abstracts
5. OPENING LECTURE - Human Health and Well-being: Balancing Between Flavor and Gut Microbiota
6. PLENARY LECTURE 1 - Clinical proteomics: More precision in precision oncology - adding phosphoproteomics to the molecular tumor board
7. PLENARY LECTURE 2 - Sepsis associated acute kidney injury
8. PLENARY LECTURE 3 - Bone Forming Agents: Will they help to close the gap in the treatment of post-menopausal osteoporosis
9. PLENARY LECTURE 4 - Digital Twins: from Personalised Medicine to Precision Public Health.
10. IFCC SYMPOSIUM 1 - Hot topics in Laboratory Medicine
11. IFCC SYMPOSIUM 2 - Future laboratory IT systems and standardized laboratory terminology
12. EFLM SYMPOSIUM 1 - EFLM - BioMedAlliance - Laboratory Medicine and the EU in the Era of Precision Medicine
13. RBSLM SYMPOSIUM 1 - Improving quality in the extra-analytical phase
14. SYMPOSIUM 1 - New approaches for deriving and applying biological variation data for clinical use
15. SYMPOSIUM 2 - The present and future of minimal residual disease (MRD) assessment
16. SYMPOSIUM 3 - AntiMicrobial Stewardship in real praxis
17. ROUND-TABLE 1 - Beyond the Numbers: Integrating Laboratory and Clinical Perspectives on Thyroid Health
18. IFCC SYMPOSIUM 3 - Unraveling the Role of Machine Learning in Clinical Chemistry: Bridging the Gap between Potential and Practicality
19. EFLM SYMPOSIUM 2 - Value Based Healthcare in Laboratory Medicine
20. RBSLM SYMPOSIUM 2 - From preanalytical to postanalytical phase in hematology/hemostasis laboratories
21. SYMPOSIUM 4 - Defining analytical performance requirements for laboratory tests to make them fit for clinical purpose
22. SYMPOSIUM 5 - Sustainable Reference intervals and Clinical Decision Limits: Towards Standardization & Harmonization
23. SYMPOSIUM 6 - Environmental Impact of Laboratory Medicine (Green and Sustainable Medical Laboratories)
24. ROUND-TABLE 2 - Health Economics: Transforming Laboratory Data into Value
25. IFCC SYMPOSIUM 4 - Cardiac troponins; clinical utility, analytical performance and future opportunities
26. SYMPOSIUM 7 - Medical test standardization in the era of Metrological Traceability: who is accountable?
27. SYMPOSIUM 8 - Current and Future Landscape of Tumor Markers in Clinical Use: Applications, Challenges, and Perspectives
28. SYMPOSIUM 9 - Biomarkers of the Brain: Past and Future
29. SYMPOSIUM 13 - Value of Diagnostics and Labtest around NCDs
30. ROUND-TABLE 3 - Emerging AI Applications in Laboratory Medicine
31. IFCC SYMPOSIUM 5 - What 21st century IFCC leadership should be: history, vision, implementation, and opportunities?
32. RBSLM SYMPOSIUM 3 - New EFLM approaches to urinalysis and urine bacterial culture
33. SYMPOSIUM 10 - How can we integrate proteomics and metabolomics in Clinical Lab?
34. SYMPOSIUM 11 - Quality Assurance in Autoimmunity
35. SYMPOSIUM 12 - AI in the extranalytical phases
36. SYMPOSIUM 14 - Integrating Recent Basic Biomolecular Achievements in Medical Practice - Diagnostics & Therapy
37. Poster Abstracts
38. Accreditation, Patient Safety, Risk management, Quality Assurance, Audit
39. Artificial intelligence, clinical decision support and machine learning
40. Cardiovascular disease; risk assessment; lipids; lipoproteins; cardiac markers
41. Clinical Chemistry
42. Data Science , Digital health, big data and smart technologies
43. Demand/test utilization management
44. Disease specific biomarkers: autoimmune, bone, cardiac, cancer, diabetes, neurological, sepsis, traumatic brain injury, …
45. Emerging & Analytical technologies, applications and limitations
46. Emerging biomarkers (-omics type, …)
47. Endocrinology
48. Evidence based medicine, including Guidelines
49. Genetic diseases
50. Geriatric testing
51. Green laboratories
52. Healthcare reform: from curative to preventive
53. Hematology and hemostasis
54. Immunology
55. Kidney diseases and transplantation, urinalysis, urinary biomarkers
56. Laboratory consolidation, Total lab automation and process design
57. Laboratory Information Systems and globalization of NPU
58. Laboratory Management, Medical leadership
59. Metabolic diseases
60. Metrological traceability and test standardization/harmonization
61. Microbiology - Infectious diseases including COVID 19
62. Molecular diagnostics, including CTC and ctDNA
63. Neonatal and paediatric laboratory medicine, including prenatal testing
64. Nutrition Trace Elements and Vitamins
65. Point of Care testing, critical care, emergency medicine
66. Precision Diagnostics and Precision Medicine
67. Recruitment, Education and Training of workforces in Laboratory Medicine
68. Reference Intervals: Direct/Indirect; population vs personal reference intervals
69. Regulations and Regulatory Science, including suboptimal tests and post-market follow-up
70. Remote monitoring and preanalytical challenges
71. Test Evaluation, outcome studies, clinical utility of biomarkers
72. Total Test process, including preanalytics, analytics and postanalytics
73. Toxicology and TDM
74. Others